AstraZeneca and Daiichi Sankyo’s Biologics License Application (BLA) for datopotamab deruxtecan (Dato-DXd) has been accepted in the US for the treatment of adult patients...
Advances include faster and more robust protein structure prediction; higher-quality models of protein/protein interactions; large-scale screening and improved de novo protein design for therapeutics
OpenFold,...
InveniAI® LLC, a global leader in the application of artificial intelligence (AI) and machine learning (ML) tools to revolutionize drug discovery and development, announces a...
Sequoia Biotech Consulting (Sequoia), a leading life sciences consulting firm renowned for its expertise in scaling life science organizations to deliver high-quality therapeutics, diagnostics,...
-- Transformational degrader antibody conjugate company backed by leading syndicate including founding investor Versant Ventures, MPM BioImpact, Decheng Capital and Eli Lilly & Company...
T-Mode TM AI by Clarius creates a split screen during an exam that displays a colorful anatomical image with labels next to the grayscale ultrasound image
Clarius...
Collaboration to leverage VantAI's expertise in generative AI and geometric deep learning to identify molecular glues against targets of interest with an option to...
Roche announced that it has entered into an agreement with PathAI, a global leader in artificial intelligence (AI)-powered technology for pathology.
Under the terms of...
Enable Medicine, a leader in AI for biological research and drug discovery, has announced the appointment of Kamni Vijay as Chief Executive Officer. She...
Designation for BXCL701 in combination with a checkpoint inhibitor (CPI) for treatment of patients with metastatic SCNC with progression on chemotherapy and no evidence...